glp-1 shots for weight loss GLP-1s Loss: What You Need to Know GLP-1 Weight Loss Injections: 10

For treatment costs, we assumed full adherence to medications, and derived medication costs directly from the Australian Pharmaceutical Benefits Scheme ( The most common SGLT2i in Australia in 2020 was empagliflozin

Epithalon is not approved for human use in non-research settings

10.1016/j.cell.2014.03.065 52 RaoR

The World Mental Health (WMH) survey, using the WHO Composite International Diagnostic Interview (CIDI 3.0), identified BD as one of the most disabling psychiatric conditions, with affected individuals averaging 41.2 days of role impairment per year 36.5 of which were directly attributed to BD (Grande et al., 2016

We have worked with some of the worlds leading life sciences players on their most significant reputational or commercial challenges